Clinical Trials Browser

Phase 4 × Nausea × Breast × Clear all

NCT00092183 2017-05-05

An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)

Phase 4 Completed

Breast Neoplasms, Nausea, Vomiting